Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HOOK Hookipa Pharma Inc

Market Closed 05-17 16:00:00 EDT

0.8154

+0.0044

+0.54%

盘后0.8184

+0.0030+0.37%

19:46 EDT

High0.8400	Low0.8020	Vol282.04K
Open0.8110	D1 Closing0.8110	Amplitude4.69%
Mkt Cap80.68M	Tradable Cap47.55M	Total Shares98.95M
T/O231.25K	T/O Rate0.48%	Tradable Shares58.31M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"HOOK","market":"US","secType":"STK","nameCN":"Hookipa Pharma Inc","latestPrice":0.8154,"timestamp":1715976000000,"preClose":0.811,"halted":0,"volume":282037,"hourTrading":{"tag":"盘后","latestPrice":0.8184,"preClose":0.8154,"latestTime":"19:46 EDT","volume":14221,"amount":11456.4801,"timestamp":1715989561035},"delay":0,"floatShares":58312594,"shares":98950107,"eps":-0.435963,"marketStatus":"Market Closed","change":0.0044,"latestTime":"05-17 16:00:00 EDT","open":0.811,"high":0.84,"low":0.802,"amount":231252.2614283,"amplitude":0.046856,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.435963,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1555560000000,"exchange":"NASDAQ","adjPreClose":0.811,"preHourTrading":{"tag":"盘前","latestPrice":0.819,"preClose":0.811,"latestTime":"09:27 EDT","volume":2611,"amount":2145.8910816,"timestamp":1715952421207},"postHourTrading":{"tag":"盘后","latestPrice":0.8184,"preClose":0.8154,"latestTime":"19:46 EDT","volume":14221,"amount":11456.4801,"timestamp":1715989561035},"volumeRatio":0.5671264898935565},"requestUrl":"/m/hq/s/HOOK","defaultTab":"news","newsList":[{"id":"2436626985","title":"Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2436626985","media":"InvestorPlace","top":-1,"share":"https://ttm.financial/m/news/2436626985?lang=en_us&edition=fundamental","pubTime":"2024-05-17 02:27","pubTimestamp":1715884046,"startTime":"0","endTime":"0","summary":"Lilium : Lilium’s eVTOL business could attract speculators.BlackSky Technology : BlackSky could ride the burgeoning space economy trend.Avino Silver & Gold : Avino Silver & Gold could benefit from the fear trade.Place your bets on these wild but compelling penny stocks to buy.Source: T. Schneider / Shutterstock.comA specialist in the field of electric vertical takeoff and landing  aircraft, Lilium  understandably ranks among the most popular penny stocks to buy. That’s evidenced by the consensus moderate buy view among Wall Street analysts. Further, the average price target calls for a rise to $2, which implies roughly 52% upside potential.Further, another risk factor to keep in mind is that Lilium is a pre-revenue enterprise. That said, there is anticipated financial momentum. For fiscal 2024, covering experts believe that Lilium will post a loss of 59 cents per share, an improvement over last year’s loss of 77 cents.As part of the burgeoning space economy, it’s easy to see w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/05/penny-stock-sleepers-7-under-the-radar-gems-ready-to-launch/","is_publish_highlight":false,"gpt_icon":0},{"id":"2435564620","title":"Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435564620","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2435564620?lang=en_us&edition=fundamental","pubTime":"2024-05-14 16:40","pubTimestamp":1715676031,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexeo Therapeutics, Inc. (LXEO – Research Report), RAPT Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lexeo-therapeutics-inc-lxeo-rapt-therapeutics-rapt-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lexeo-therapeutics-inc-lxeo-rapt-therapeutics-rapt-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434822118","title":"HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2434822118","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2434822118?lang=en_us&edition=fundamental","pubTime":"2024-05-11 20:36","pubTimestamp":1715430995,"startTime":"0","endTime":"0","summary":"NasdaqCM:HOOK Earnings and Revenue Growth May 11th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates significantly. Earnings per share  also surpassed analyst estimates.Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Biotechs industry in the US.The company's shares are down 17% from a week ago.It's necessary to consider the ever-present spectre of investment risk.   We've identified 6 warning signs  with HOOKIPA Pharma , and understanding them should be part of your investment process.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hookipa-pharma-first-quarter-2024-123635620.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434010669","title":"Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2434010669","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434010669?lang=en_us&edition=fundamental","pubTime":"2024-05-10 00:40","pubTimestamp":1715272807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hookipa Pharma (HOOK – Research Report) and Femasys ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hookipa-pharma-hook-and-femasys-femy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hookipa-pharma-hook-and-femasys-femy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434093670","title":"HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beats $(0.10) Estimate, Sales $36.599M Beat $2.800M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093670","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2434093670?lang=en_us&edition=fundamental","pubTime":"2024-05-09 19:15","pubTimestamp":1715253343,"startTime":"0","endTime":"0","summary":"HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10) by 210 percent. This is a 140.74 percent increase over losses of $(0.27) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38727159/hookipa-pharma-q1-2024-gaap-eps-0-11-beats-0-10-estimate-sales-36-599m-beat-2-800m-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2434093614","title":"HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093614","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2434093614?lang=en_us&edition=fundamental","pubTime":"2024-05-09 11:01","pubTimestamp":1715223660,"startTime":"0","endTime":"0","summary":"Phase2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and Dru","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/09/2878623/0/en/HOOKIPA-Pharma-Reports-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431352895","title":"Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2431352895","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2431352895?lang=en_us&edition=fundamental","pubTime":"2024-04-30 14:12","pubTimestamp":1714457531,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), BioMarin Pharmaceuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-biomarin-pharmaceutical-bmrn-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-edwards-lifesciences-ew-biomarin-pharmaceutical-bmrn-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2430717403","title":"HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2430717403","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2430717403?lang=en_us&edition=fundamental","pubTime":"2024-04-25 11:01","pubTimestamp":1714014060,"startTime":"0","endTime":"0","summary":"Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback HB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/25/2869506/0/en/HOOKIPA-Pharma-Announces-Pivotal-Phase-2-3-Trial-Design-for-HB-200-in-Combination-with-Pembrolizumab.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429439716","title":"HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429439716","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2429439716?lang=en_us&edition=fundamental","pubTime":"2024-04-24 11:01","pubTimestamp":1713927660,"startTime":"0","endTime":"0","summary":"NEW YORK and VIENNA, Austria, April  24, 2024  (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenav","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/24/2868480/0/en/HOOKIPA-Pharma-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-HB-700-for-the-Treatment-of-KRAS-Mutated-Cancers.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hookipapharma.com","stockEarnings":[{"period":"1week","weight":0.0617},{"period":"1month","weight":0.0694},{"period":"3month","weight":0.2336},{"period":"6month","weight":0.5711},{"period":"1year","weight":-0.396},{"period":"ytd","weight":0.0067}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.081948},{"month":2,"riseRate":0.6,"avgChangeRate":0.127152},{"month":3,"riseRate":0.2,"avgChangeRate":-0.060883},{"month":4,"riseRate":0.8,"avgChangeRate":0.068686},{"month":5,"riseRate":0.666667,"avgChangeRate":0.075273},{"month":6,"riseRate":0.2,"avgChangeRate":-0.196456},{"month":7,"riseRate":0.2,"avgChangeRate":-0.100672},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021749},{"month":9,"riseRate":0.2,"avgChangeRate":-0.071488},{"month":10,"riseRate":0.2,"avgChangeRate":-0.085183},{"month":11,"riseRate":0.6,"avgChangeRate":0.054413},{"month":12,"riseRate":0.4,"avgChangeRate":0.014958}],"exchange":"NASDAQ","name":"Hookipa Pharma Inc","nameEN":"Hookipa Pharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hookipa Pharma Inc(HOOK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hookipa Pharma Inc,HOOK,Hookipa Pharma Inc股票,Hookipa Pharma Inc股票老虎,Hookipa Pharma Inc股票老虎国际,Hookipa Pharma Inc行情,Hookipa Pharma Inc股票行情,Hookipa Pharma Inc股价,Hookipa Pharma Inc股市,Hookipa Pharma Inc股票价格,Hookipa Pharma Inc股票交易,Hookipa Pharma Inc股票购买,Hookipa Pharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hookipa Pharma Inc(HOOK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction